| Bioactivity | CHS-114 (SRF-114) is a fully human IgG1 antibody that targets CCR8. CHS-114 has the potential for the study of head and neck squamous cell carcinoma (HNSCC). The isotype control for CHS-114 can refer to Human IgG1 kappa, Isotype Control (HY-P99001)[1]. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. N. Rajasekaran, et al. CHS-114: A Cytolytic Anti-CCR8 Antibody that Depletes Tumor-infiltrating Regulatory T Cells as a Treatment for Head and Neck Squamous Cell Carcinoma. Volume 118, Issue 5e89April 01, 2024. |